Sponsors to FDA: Informed Consent Changes Will Befuddle Patients

Clinical Trials Advisor
Sponsors say an FDA plan to require informed consent documents to include detailed descriptions of treatment alternatives to experimental drugs could confuse patients such that recruiting clinical trial subjects will be nearly impossible, drugmakers argue.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00